Release Date: 14/04/10 09:19 Summary: Final Director's Interest Notice - BC Price Sensitive: No Download Document 9.09KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%